Φορτώνει......
Safety of long-term intrathecal methotrexate in progressive forms of MS
BACKGROUND: There are few treatment options for multiple sclerosis (MS) patients with advanced disability [expanded disability status scale (EDSS) ⩾ 6.0]. In 2010, we reported initial results of using intrathecal methotrexate (ITMTX) in patients with progressive MS. We now report on long-term use of...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Ther Adv Neurol Disord |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
SAGE Publications
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6891004/ https://ncbi.nlm.nih.gov/pubmed/31832101 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286419892360 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|